blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP4034117

EP4034117 - PEDIATRIC TRAZODONE COMPOSITIONS AND METHOD OF TREATMENT THEREOF [Right-click to bookmark this link]
StatusExamination is in progress
Status updated on  01.12.2023
Database last updated on 06.07.2024
FormerRequest for examination was made
Status updated on  01.07.2022
FormerThe international publication has been made
Status updated on  03.04.2021
Formerunknown
Status updated on  09.10.2020
Most recent event   Tooltip23.03.2024New entry: Reply to examination report 
Applicant(s)For all designated states
Angelini S.p.A.
Viale Amelia, 70
00181 Roma / IT
[2022/31]
Inventor(s)01 / CALISTI, Fabrizio
Via Tito Omboni, 148
00147 ROMA / IT
02 / RAGNI, Lorella
Via Tommasi, 17
60033 CHIARAVALLE (AN) / IT
03 / TONGIANI, Serena
Via dei Laghi, 23
00046 GROTTAFERRATA (RM) / IT
04 / PICOLLO, Rossella
Via Marciano di Eraclea, 41
00124 ROMA / IT
05 / OGGIANU, Laura
Via Beniamino Segre, 81
00134 ROMA / IT
 [2022/31]
Representative(s)Merli, Silvia, et al
Marchi & Partners S.r.l.
Via Vittor Pisani, 13
20124 Milano / IT
[2022/31]
Application number, filing date20781357.725.09.2020
[2022/31]
WO2020EP77017
Priority number, dateUS201962906166P26.09.2019         Original published format: US 201962906166 P
[2022/31]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2021058810
Date:01.04.2021
Language:EN
[2021/13]
Type: A1 Application with search report 
No.:EP4034117
Date:03.08.2022
Language:EN
The application published by WIPO in one of the EPO official languages on 01.04.2021 takes the place of the publication of the European patent application.
[2022/31]
Search report(s)International search report - published on:EP01.04.2021
ClassificationIPC:A61K31/497, A61P25/20
[2022/31]
CPC:
A61K31/497 (EP,IL,US); A61K31/496 (CN,KR); A61K45/06 (CN);
A61K47/10 (CN,KR); A61K47/12 (CN,KR); A61K47/14 (CN,KR);
A61K9/0095 (CN,KR,US); A61K9/08 (KR); A61P25/00 (CN);
A61P25/14 (CN); A61P25/20 (EP,CN,IL,KR,US); A61K2300/00 (KR);
A61K9/0053 (US) (-)
C-Set:
A61K31/496, A61K2300/00 (CN)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2022/31]
Extension statesBA12.04.2022
ME12.04.2022
Validation statesMA12.04.2022
MD12.04.2022
TitleGerman:PÄDIATRISCHE TRAZODON-ZUSAMMENSETZUNGEN UND VERFAHREN ZU IHRER BEHANDLUNG[2022/31]
English:PEDIATRIC TRAZODONE COMPOSITIONS AND METHOD OF TREATMENT THEREOF[2022/31]
French:COMPOSITIONS PÉDIATRIQUES DE TRAZODONE ET PROCÉDÉ DE TRAITEMENT ASSOCIÉ[2022/31]
Entry into regional phase12.04.2022National basic fee paid 
12.04.2022Designation fee(s) paid 
12.04.2022Examination fee paid 
Examination procedure12.04.2022Examination requested  [2022/31]
12.04.2022Date on which the examining division has become responsible
25.10.2022Amendment by applicant (claims and/or description)
01.12.2023Despatch of a communication from the examining division (Time limit: M04)
22.03.2024Reply to a communication from the examining division
Fees paidRenewal fee
12.04.2022Renewal fee patent year 03
21.09.2023Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[XD]WO2009016069  (ACRAF [IT], et al) [XD] 6,9 * the whole document * * examples 6-10 *;
 [A]  - BRUNI OLIVIERO ET AL, "Practitioner Review: Treatment of chronic insomnia in children and adolescents with neurodevelopmental disabilities", JOURNAL OF CHILD PSYCHOLOGY AND PSYCHIATRY, WILEY-BLACKWELL PUBLISHING, GB, (20180430), vol. 59, no. 5, doi:10.1111/JCPP.12812, ISSN 1469-7610, pages 489 - 508, XP009524511 [A] 1-15 * the whole document * * page 495; table 2 * * page 499, column 2, paragraph 4 - page 500, column 1, paragraph 2 *

DOI:   http://dx.doi.org/10.1111/jcpp.12812
 [AD]  - ALLISON BECK BLACKMER ET AL, "Management of Sleep Disorders in Children With Neurodevelopmental Disorders: A Review", PHARMACOTHERAPY, US, (20160101), vol. 36, no. 1, doi:10.1002/phar.1686, ISSN 0277-0008, pages 84 - 98, XP055758040 [AD] 1-15 * the whole document * * page 91; table 1 *

DOI:   http://dx.doi.org/10.1002/phar.1686
 [AD]  - OWENS J A ET AL, "Use of pharmacotherapy for insomnia in child psychiatry practice: A national survey", SLEEP MEDICINE, ELSEVIER, AMSTERDAM, NL, vol. 11, no. 7, ISSN 1389-9457, (20100801), pages 692 - 700, (20100719), XP027155818 [AD] 1-15 * the whole document * * page 694, column 2, paragraph 3 *
 [A]  - KALLEPALLI B R ET AL, "TRAZODONE IS ONLY SLIGHTLY FASTER THAN FLUOXETINE IN RELIEVING INSOMNIA IN ADOLESCENTS WITH DEPRESSIVE DISORDERS", JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, NEW YORK, NY, US, (19970101), vol. 7, no. 2, ISSN 1044-5463, pages 97 - 107, XP009000451 [A] 1-15 * abstract *
 [A]  - PRANZATELLI ET AL, "Sleep Disturbance and Rage Attacks in Opsoclonus-Myoclonus Syndrome: Response to Trazodone", JOURNAL OF PEDIATRICS, MOSBY-YEAR BOOK, ST. LOUIS, MO, US, (20050901), vol. 147, no. 3, doi:10.1016/J.JPEDS.2005.05.016, ISSN 0022-3476, pages 372 - 378, XP005086826 [A] 1-15 * the whole document * * page 374, column 1, paragraph 4 - column 2, paragraph 1 *

DOI:   http://dx.doi.org/10.1016/j.jpeds.2005.05.016
 [XP]  - LAURA OGGIANU ET AL, "Estimation of an Appropriate Dose of Trazodone for Pediatric Insomnia and the Potential for a Trazodone-Atomoxetine Interaction", CPT: PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, (20200111), vol. 9, no. 2, doi:10.1002/psp4.12480, ISSN 2163-8306, pages 77 - 86, XP055758080 [XP] 1-4 * the whole document * * page 84, column 2, paragraph 2 *

DOI:   http://dx.doi.org/10.1002/psp4.12480
by applicantIN1242MUM2005
 WO2009016069
    - BLACKMER A. BFEINSTEIN J. A., "Management of Sleep Disorders in Children With Neurodevelopmental Disorders: A Review", Pharmacotherapy, (20160000), vol. 36, no. 1, pages 84 - 98
    - OWENS J. A. et al., "Use of pharmacotherapy for insomnia in child psychiatry practice: A national survey", Sleep Medicine, (20100000), vol. 11, pages 692 - 700, XP027155818
    - THAPAR ACOOPER MRUTTER M, "Neurodevelopmental disorders", Lancet Psychiatry, (20170400), vol. 4, no. 4, pages 339 - 346
    - ANGRIMAN MCARAVALE BNOVELLI LFERRI RBRUNI O, "Sleep in children with neurodevelopmental disabilities", Neuropediatrics, (20150600), vol. 46, no. 3, pages 199 - 210
    - JAFFER KYCHANG TVANLE B et al., "Trazodone for Insomnia: A Systematic Review", Innov Clin Neurosci, (20170000), vol. 14, no. 7-8, pages 24 - 34
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.